Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
C Max |
57.0 |
ng/ml |
57.0 |
ng/ml |
intravenous injection, IV; |
DRUGBANK |
C Max |
112.0 |
ng/ml |
112.0 |
ng/ml |
intravenous injection, IV; |
DRUGBANK |
C Max |
86.5 |
ng/ml |
67-106 |
ng/ml |
intravenous injection, IV; |
DRUGBANK |
C Max |
104.5 |
ng/ml |
89-120 |
ng/ml |
intravenous injection, IV; |
DRUGBANK |
Clearance |
102.0 |
L/h |
102.0 |
L/h |
Average clearance; |
DRUGBANK |
Clearance |
112.0 |
L/h |
112.0 |
L/h |
Average clearance; |
DRUGBANK |
Clearance |
15.0 |
L/h |
15.0 |
L/h |
Average clearance; |
DRUGBANK |
Clearance |
32.0 |
L/h |
32.0 |
L/h |
Average clearance; |
DRUGBANK |
Clearance |
1.1 |
L/h/kg |
19 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
1191.0 |
L/m2 |
498-1884 |
L/m2 |
Average volume of distribution; multiple myeloma; patients; |
DRUGBANK |
Volume of Distribution |
10.0 |
L/kg |
10 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
116.5 |
h |
40-193 |
h |
elimination half-life; Multiple dose; |
DRUGBANK |
Half-life |
92.0 |
h |
76-108 |
h |
Multiple dose; |
DRUGBANK |
Half-life |
18.0 |
h |
18 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Toxicity TDLo |
0.36 |
mg/kg/day |
5.0 |
mg/kg/14D |
mouse; |
DRUGBANK |
Toxicity TDLo |
0.13 |
mg/kg/day |
1.6 |
mg/kg/12D |
mouse; |
DRUGBANK |
Protein Binding |
83.0 |
% |
~83 |
% |
plasma proteins; human, homo sapiens; |
DRUGBANK |